Systematic review / meta-analysis / 2021
Astragalus-containing herbal medicine combined with chemotherapy improved tumor response and reduced toxicity in cervical cancer patients.
A systematic review and meta-analysis of 19 randomized controlled trials evaluated the efficacy of Astragalus-containing Chinese herbal medicine (CHM) combined with chemotherapy (CT) for cervical cancer. Compared with the control group, Astragalus-containing CHM combined with CT significantly increased tumor response (RR = 1.25, 95% CI: 1.17-1.33, p < 0.00001) and Karnofsky performance score (SMD = 1.81, 95% CI: 1.46-2.17, p < 0.00001). The combined group also demonstrated remarkably reduced CT toxicity.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- Patients with cervical cancer across 19 trials
- What was measured
- Tumor response (complete and partial response), Karnofsky performance score, and chemotherapy toxicity
THE PAPER
Astragalus-Containing Chinese Herbal Medicine Combined With Chemotherapy for Cervical Cancer: A Systematic Review and Meta-Analysis.
Shen L, Gwak SR, Cui ZY, Joo JC, Park SJ. Front Pharmacol, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.